Angiographic Catheters Market by Product, Distribution Channel, Application, End-User

List of Tables

The Angiographic Catheters Market is projected to reach USD 1.84 billion by 2030 from USD 1.14 billion in 2022, at a CAGR of 6.15% during the forecast period.

Global Angiographic Catheters Market

KEY MARKET STATISTICS
Base Year Value [2022]	USD 1.14 billion
Estimated Year Value [2023]	USD 1.20 billion
Forecast Year Value [2030]	USD 1.84 billion
CAGR (%)	6.15%

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Angiographic Catheters Market.

Based on Product, market is studied across Conventional Catheters, Cutting Balloon Catheters, Drug Eluting Balloon (Deb) Catheters, and Scoring Balloon Catheters. The Drug Eluting Balloon (Deb) Catheters is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies. The Online Pharmacies is projected to witness significant market share during forecast period.

Based on Application, market is studied across Coronary, Endovascular, Neurology, and Oncology. The Oncology is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Ambulatory Surgical Centers, Hospital, and Specialty Clinics. The Ambulatory Surgical Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Angiographic Catheters Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Angiographic Catheters Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Angiographic Catheters Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advin Health Care, AngioDynamics Inc., Asahi Intecc Co., Ltd., B. Braun, Becton, Dickinson and Company, Bio X, Bioteque Corporation, Boston Scientific Corp., Cardinal Health, Cardiomac India (P) Ltd., Cook Group Incorporated, Edwards Lifesciences, Johnson & Johnson Services, Inc., McKesson Medical-Surgical Inc., Medtronic PLC, Merit Medical Systems, Microport Scientific Corp., Nipro Corp., Pediavascular, Penumbra, Inc., Stryker Corporation, Teleflex Inc., Terumo Corporation, and Wellinq.

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Angiographic Catheters Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Angiographic Catheters Market?

3. What is the competitive strategic window for identifying opportunities in the Angiographic Catheters Market?

4. What are the latest technology trends and regulatory frameworks in the Angiographic Catheters Market?

5. What is the market share of the leading vendors in the Angiographic Catheters Market?

6. Which modes and strategic moves are suitable for entering the Angiographic Catheters Market?

Product Code: MRR-B16853778241

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Angiographic Catheters Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing incidence of cardiovascular diseases globally
  - 5.1.1.2. Rise in demand for minimally invasive procedures
  - 5.1.1.3. Growth in the number of people suffering from diabetes and the adoption of unhealthy lifestyles
- 5.1.2. Restraints
  - 5.1.2.1. Huge cost associated with angiographic procedures
- 5.1.3. Opportunities
  - 5.1.3.1. Growth in R&D activities for angiographic procedures
  - 5.1.3.2. Technological advancements and developments in angiographic surgeries
- 5.1.4. Challenges
  - 5.1.4.1. High risk associated with the procedure of angiographic surgeries
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Angiographic Catheters Market, by Product

6.1. Introduction
6.2. Conventional Catheters
6.3. Cutting Balloon Catheters
6.4. Drug Eluting Balloon (Deb) Catheters
6.5. Scoring Balloon Catheters

7. Angiographic Catheters Market, by Distribution Channel

7.1. Introduction
7.2. Hospital Pharmacies
7.3. Online Pharmacies
7.4. Retail Pharmacies

8. Angiographic Catheters Market, by Application

8.1. Introduction
8.2. Coronary
8.3. Endovascular
8.4. Neurology
8.5. Oncology

9. Angiographic Catheters Market, by End-User

9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Hospital
9.4. Specialty Clinics

10. Americas Angiographic Catheters Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Angiographic Catheters Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Angiographic Catheters Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
- 14.1.1. Abbott Laboratories
- 14.1.2. Advin Health Care
- 14.1.3. AngioDynamics Inc.
- 14.1.4. Asahi Intecc Co., Ltd.
- 14.1.5. B. Braun
- 14.1.6. Becton, Dickinson and Company
- 14.1.7. Bio X
- 14.1.8. Bioteque Corporation
- 14.1.9. Boston Scientific Corp.
- 14.1.10. Cardinal Health
- 14.1.11. Cardiomac India (P) Ltd.
- 14.1.12. Cook Group Incorporated
- 14.1.13. Edwards Lifesciences
- 14.1.14. Johnson & Johnson Services, Inc.
- 14.1.15. McKesson Medical-Surgical Inc.
- 14.1.16. Medtronic PLC
- 14.1.17. Merit Medical Systems
- 14.1.18. Microport Scientific Corp.
- 14.1.19. Nipro Corp.
- 14.1.20. Pediavascular
- 14.1.21. Penumbra, Inc.
- 14.1.22. Stryker Corporation
- 14.1.23. Teleflex Inc.
- 14.1.24. Terumo Corporation
- 14.1.25. Wellinq
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing